The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Molecular profiling of resected esophageal cancer and its correlation with clinical outcome.
Tomoya Yokota
Honoraria - Merck; Merck Serono
Masakuni Serizawa
No relevant relationships to disclose
Ayumu Hosokawa
Honoraria - Yakult Honsha
Kimihide Kusafuka
No relevant relationships to disclose
Keita Mori
No relevant relationships to disclose
Toshiro Sugiyama
Honoraria - AstraZeneca; Novartis
Research Funding - AstraZeneca; Novartis; Pfizer
Yasuhiro Tsubosa
No relevant relationships to disclose
Yasuhiro Koh
Honoraria - Illumina